Tekla Healthcare Investors Stock Analysis

HQH Stock  USD 16.58  0.07  0.42%   
Tekla Healthcare Investors is undervalued with Real Value of 17.43 and Hype Value of 16.57. The main objective of Tekla Healthcare stock analysis is to determine its intrinsic value, which is an estimate of what Tekla Healthcare Investors is worth, separate from its market price. There are two main types of Tekla Healthcare's stock analysis: fundamental analysis and technical analysis.
The Tekla Healthcare stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Tekla Healthcare's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Tekla Healthcare Investors. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.

Tekla Stock Analysis Notes

About 24.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 0.82. Some equities with similar Price to Book (P/B) outperform the market in the long run. Tekla Healthcare Inv last dividend was issued on the 21st of February 2025. Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. Tekla Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States. Tekla Healthcare operates under Asset Management classification in the United States and is traded on New York Stock Exchange. To learn more about Tekla Healthcare Investors call Daniel Omstead at 215 405 5700 or check out https://www.teklacap.com/hqh.html.

Tekla Healthcare Quarterly Total Revenue

5.46 Million

Tekla Healthcare Inv Investment Alerts

Tekla Healthcare Inv has high likelihood to experience some financial distress in the next 2 years
Tekla Healthcare Investors has about 62 in cash with (65.41 M) of positive cash flow from operations.
Tekla Healthcare Inv has a poor financial position based on the latest SEC disclosures
Latest headline from news.google.com: Technical Data - Stock Traders Daily

Tekla Market Capitalization

The company currently falls under 'Small-Cap' category with a total capitalization of 864.31 M.

Tekla Profitablity

The company has Net Profit Margin of 17.17 %, which may imply that it executes well on its competitive polices and has reasonable control over its expenses and variable costs. This is very large. In the same way, it shows Net Operating Margin of (0.03) %, which entails that for every $100 of revenue, it lost $0.03.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.17  0.18 
Return On Assets 0.17  0.18 
Return On Equity 0.17  0.18 

Management Efficiency

As of now, Tekla Healthcare's Return On Tangible Assets are decreasing as compared to previous years. The Tekla Healthcare's current Return On Assets is estimated to increase to 0.18, while Return On Capital Employed is projected to decrease to (0.0002). As of now, Tekla Healthcare's Non Currrent Assets Other are increasing as compared to previous years. The Tekla Healthcare's current Return On Tangible Assets is estimated to increase to 0.18, while Total Assets are projected to decrease to under 690.6 M. Tekla Healthcare's management efficiency ratios could be used to measure how well Tekla Healthcare manages its routine affairs as well as how well it operates its assets and liabilities.
Last ReportedProjected for Next Year
Book Value Per Share 20.33  26.40 
Tangible Book Value Per Share 20.33  26.40 
Price Book Value Ratio 0.79  1.00 
Price Fair Value 0.79  1.00 
Enterprise Value836.7 MB
At Tekla Healthcare Inv, management's focus on innovation and efficiency has led to impressive financial results. We assess these factors to determine the stock's attractiveness to investors.
Dividend Yield
0.1375
Operating Margin
(0.03)
Profit Margin
17.1736
Forward Dividend Yield
0.1375
Beta
0.748

Technical Drivers

As of the 27th of March, Tekla Healthcare has the Risk Adjusted Performance of 0.0675, coefficient of variation of 1282.57, and Semi Deviation of 0.9169. Tekla Healthcare technical analysis provides you with a way to harness past market data to determine a pattern that measures the direction of the company's future prices.

Tekla Healthcare Inv Price Movement Analysis

Execute Study
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Tekla Healthcare middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Tekla Healthcare Inv. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Tekla Healthcare Inv Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Tekla Healthcare insiders, such as employees or executives, is commonly permitted as long as it does not rely on Tekla Healthcare's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Tekla Healthcare insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Tekla Healthcare Outstanding Bonds

Tekla Healthcare issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Tekla Healthcare Inv uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Tekla bonds can be classified according to their maturity, which is the date when Tekla Healthcare Investors has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Tekla Healthcare Predictive Daily Indicators

Tekla Healthcare intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Tekla Healthcare stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Tekla Healthcare Corporate Filings

F3
20th of March 2025
The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock
ViewVerify
28th of February 2025
Other Reports
ViewVerify
F3
20th of December 2024
The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock
ViewVerify
16th of December 2024
Other Reports
ViewVerify
9th of December 2024
Other Reports
ViewVerify
27th of November 2024
Other Reports
ViewVerify
F3
18th of November 2024
An amendment to the original Schedule 13D filing
ViewVerify
F3
22nd of October 2024
An amendment to the original Schedule 13D filing
ViewVerify

Tekla Healthcare Forecast Models

Tekla Healthcare's time-series forecasting models are one of many Tekla Healthcare's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Tekla Healthcare's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Tekla Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Tekla Healthcare prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Tekla shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Tekla Healthcare. By using and applying Tekla Stock analysis, traders can create a robust methodology for identifying Tekla entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin 17.17  17.69 
Operating Profit Margin(0.02)(0.02)
Net Profit Margin 17.17  17.69 

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Tekla Healthcare to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Latest Portfolios Now

   

Latest Portfolios

Quick portfolio dashboard that showcases your latest portfolios
All  Next Launch Module

Complementary Tools for Tekla Stock analysis

When running Tekla Healthcare's price analysis, check to measure Tekla Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tekla Healthcare is operating at the current time. Most of Tekla Healthcare's value examination focuses on studying past and present price action to predict the probability of Tekla Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tekla Healthcare's price. Additionally, you may evaluate how the addition of Tekla Healthcare to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Fundamental Analysis
View fundamental data based on most recent published financial statements
Money Managers
Screen money managers from public funds and ETFs managed around the world
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account